基本信息
-
(4R,12aS)-N-(2,4-二氟苄基)-7-苯氧基-4-甲基-6,8-二氧-
-
1206102-11-5
-
度鲁特韦中间体2; 德罗特韦 Bn-N-1; (4R,12AS)-N-(2,4-二氟苄基)-7-苯氧基-4-甲基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷-9-甲酰胺
-
C27H25F2N3O5
-
509.509
-
(4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
-
-
1.42±0.1 g/cm3(Predicted)
-
(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-7-(phenylmethoxy)-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
-
-
-
761.7±60.0 °C(Predicted)
-
详细信息
(4R,12AS)-N-(2,4-二氟苄基)-7-苯氧基-4-甲基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1'''',2'''':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷-9-甲酰胺;(4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-4-甲基-6,8-二氧代-7-(苯基甲氧基)-2H-吡啶并[1'''',2'''':4,5]吡嗪并[2,1-B][1,3]恶嗪-9-甲酰胺;度鲁特韦中间体4。
纯度: 99%。